Registration now open for BOS Events 2025!

Dates for BOS Events 2025 are 11th and 12th June for BOS Basel 2025, and 25th and 26th November for BOS Manchester 2025. Please find further details outlining floor plans and pricing options at the event links provided.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Manchester 2025)

Logo for InnoSyn BV
InnoSyn BV
InnoSyn provides process R&D and pilot scale manufacturing services to supports its customers during all phases in the development and scale up of new and existing chemical processes.
InnoSyn offers a team of passionate & experienced problem solvers, applying innovative and cost-efficientand & cutting...
View profile

Featured Speaker (BOS Manchester 2025)

photo of Dr Grace Lee

Navigating the Complexity of Cell and Gene Therapy Development and Outsourcing

Dr Grace Lee, Founder and Consultant, Elevalue Consulting LLC

ABSTRACT: The cell and Gene Therapies (CGT) landscape is rapidly changing and is characterized by a significant upsurge in clinical trials and outsourcing endeavors.
External partnerships play a pivotal role within this framework, particularly for small—to mid-sized biotech companies with limited experience in Good Manufacturing Practice (GMP) compliance for new modalities. In this presentation, Dr. Lee will provide insight into the complexity of CGT development and the critical components to consider in outsourcing partnerships with case studies.

Click here to Read More